Item 8.01 Other Events.

On September 3, 2008, in connection with its application for extension of confidential treatment, Adolor Corporation (the "Company") re-filed that certain Option and License Agreement effective June 10, 1998 by and between the Company and Roberts Laboratories Inc. (the "Roberts Agreement") in order to include in the Company's publicly filed materials certain portions of the Roberts Agreement for which confidential treatment was previously granted but for which such treatment is no longer necessary. The Roberts Agreement was originally filed as Exhibit 10.2 to the Company's Registration Statement on Form S-1 (Registration No. 333-96333) filed on February 8, 2000. A copy of the Roberts Agreement is attached hereto as Exhibit 10.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

10.1 Option and License Agreement effective June 10, 1998 by and between Adolor Corporation and Roberts Laboratories Inc.1

1 Confidential treatment has been requested with respect to portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission.

---